Moderna surprises the Street by predicting a bigger-than …

Moderna Surprises The Street By Predicting A Bigger-Than …

2 weeks from now

2 days ago  · Moderna pulled in most of its revenue last year from its COVID-19 vaccine, Spikevax, which brought in more than $3 billion in sales. Regulators also approved a Moderna …

usnews.com

Moderna Cuts 2025 Sales Forecast By $1 Billion On Weak Vaccine …

2 weeks from now

2 days ago  · (Reuters) -Moderna (MRNA) cut its 2025 sales forecast by $1 billion on Monday, hurt by a slow adoption of its respiratory syncytial virus (RSV) shot and weak demand for COVID …

yahoo.com

Moderna's $1 Billion Revenue Forecast Cut Sends Stock

2 weeks from now

1 day ago  · Shares of Moderna dropped more than 20% intraday to $33.44, more than erasing gains last week after the first bird-flu death was reported in the U.S. The stock has lost about …

investopedia.com

Moderna's Stock Pops After Surprise Quarterly Profit, Even As …

2 weeks from now

Feb 22, 2024  · Moderna Inc. shares (MRNA) jumped more than 7% premarket on Thursday after the company reported a surprise fourth-quarter profit, even as its COVID product sales …

morningstar.com

What’s Behind The Recent Rise In MRNA Stock? - Forbes

2 weeks from now

Jan 8, 2025  · Moderna has been struggling amid its falling sales post the pandemic. For perspective, Moderna’s revenue plunged 64% y-o-y to $6.8 billion in 2023 due to lower …

forbes.com

Moderna Stock Pops After Covid Shot Obliterates Sales Views

2 weeks from now

May 4, 2022  · Despite a nearly $2 billion sales beat, Moderna restated its prediction for $21 billion in full-year advance purchase agreements for its two-shot Covid vaccine. The projection was …

investors.com

Moderna Stock Jumps After Covid Vaccine Obliterates Sales …

2 weeks from now

Aug 3, 2022  · Moderna also reiterated its view for $21 billion in full-year sales of its Covid vaccine. Analysts called for $22.2 billion in total revenue. Further, the company announced a new …

investors.com

Moderna Stock Surges 14% After Covid Vaccine-Maker Surprises …

2 weeks from now

Feb 22, 2024  · Moderna stock analysts model $321 million in sales of the company's vaccine this year. Mock notes Moderna's shot uses a pre-filled syringe, which could help it gain share from …

investors.com

Moderna's Stock Pops After Biotech Ekes Out A Surprise Profit, And ...

2 weeks from now

Nov 7, 2024  · Net product sales rose 4% to $1.8 billion in the quarter, driven by demand for the updated COVID-19 vaccine. Sales of Spikevax came to $1.8 billion, while FactSet was …

morningstar.com

Moderna Breaks Out For The First Time In A Year After Covid Shot …

2 weeks from now

On the stock market today, Moderna stock surged 12.7% to 125.59. Shares topped a buy point at 115.89 out of a cup-with-handle base, MarketSurge shows. The biotech stock last broke out of …

msn.com

Why Moderna Stock Just Crashed 21% - The Motley Fool

2 weeks from now

2 days ago  · Moderna's (MRNA-1.96%) sales are slowing down, and Moderna stock is going down -- a lot. The coronavirus vaccine maker's shares plunged 21.2% through 10:20 a.m. ET …

fool.com

Moderna Stock Crashes 21% After Covid Vaccine Maker Slashes …

2 weeks from now

1 day ago  · Moderna also cut its 2025 outlook and now projects just $1.5 billion to $2.5 billion, well below its prior view for $2.5 billion to $3.5 billion. Moderna stock crashed 20.7% to 33.50.

investors.com

Moderna Reports Surprise Profit On Higher-than-expected COVID …

2 weeks from now

Nov 7, 2024  · Moderna still expects to make less from COVID vaccine sales this year than it did in 2023, however, and reaffirmed its 2024 sales forecast of $3 billion to $3.5 billion. The …

reuters.com

Moderna (MRNA) Stock Pops 13% On Hopes For Bird Flu Vaccine

2 weeks from now

Jan 7, 2025  · Shares of MRNA stock are rising a day after the first bird-flu death was reported in the U.S. Boston-based Moderna is in the process of developing a vaccine against bird flu, …

nasdaq.com

Moderna Surges After CDC Reports Two-Week Covid Spike

2 weeks from now

Jan 7, 2025  · BioNTech and Novavax's Covid shots make up the entirety of their product sales. Moderna stock popped 11.7% to 47.53, while BioNTech shares 5.6% to 126.88. ... , which is …

investors.com